Lys-PEG3-BA
Lys-PEG3-BA is an EML4-ALK/EGFR PROTAC degrader with DC50 values of 1.32 and 19.66 μM for H3122 (EML4-ALK) and H1975 (EGFR-L858R/T790M) cells, respectively. Lys-PEG3-BA hinders proliferation via rewiring the ubiquitin- proteasome system in vitro. Lys-PEG3-BA can be used for non-small cell lung cancer research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3057939-67-7
- Fòrmula: C38H57ClN9O7P
- Peso molecular:818.34
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas PROTACs
MoreVer todos los productos específicos de isoformas EGFR
More
Actividad biológica
Descripciòn
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| NCI-H1975 | IC50 |
18.56 μM
Compound: Lys-PEG3-BA
|
Inhibition of cell viability in human NCI-H1975 cells incubated for 48 to 72 hrs by CCK8 assay
Inhibition of cell viability in human NCI-H1975 cells incubated for 48 to 72 hrs by CCK8 assay
|
[PMID: 39114932] |
In Vitro
Lys-PEG3-BA (0-20 μM) leads EML4-ALK decertation in H3122 (EML4-ALK) cells and attains a 91% reduction at 10 μM[2].
Lys-PEG3-BA (0-20 μM) specifically triggers the degradation of EGFR in H1975 (EGFR-L858R/T790M) cells, and attains a 52% reduction at 20 μM [2].
Lys-PEG3-BA (48-72 h) efficiently inhibits H3122 (EML4-ALK) and H1975 cell proliferation with an IC50s of 5.30 μM at 48 h and 18.56 μM at 72 h, respectively[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:H1975 (EGFR-L858R/T790M) and H3122 (EML4-ALK)
-
Concentration:0, 0.01, 0.1, 1, 10 and 20 μM
-
Incubation Time:48 (for H3122) or 72 h (for H1975)
-
Result:Specifically triggered the degradation of EGFR in H1975 (EGFR-L858R/T790M) cells, without affecting the wild-type EGFR protein level.
Resulted in apparent downregulation of the EML4 ALK protein in H3122 (EML4-ALK) cells at varying doses.
Chemical Information
-
No. CAS 3057939-67-7
-
Peso molecular 818.34
-
Fòrmula C38H57ClN9O7P
-
SMILES
COC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)P(C)(C)=O)=N2)C=CC(N4CCN(CC4)C(CCOCCOCCOCCNC([C@H](CCCCN)N)=O)=O)=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureza y Documentación
Referencias
[1]. Chen X, et al. Mighty mini-PROTACs: an emerging class of degraders. Eur J Med Chem. 2026 Jan 5;301:118202. [Content Brief]
[2]. Zhang J, et al. Distinct Amino Acid-Based PROTACs Target Oncogenic Kinases for Degradation in Non-Small Cell Lung Cancer (NSCLC). J Med Chem. 2024 Aug 22;67(16):13666-13680. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)